Correlation Between Maxigen Biotech and SciVision Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Maxigen Biotech and SciVision Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maxigen Biotech and SciVision Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Maxigen Biotech and SciVision Biotech, you can compare the effects of market volatilities on Maxigen Biotech and SciVision Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maxigen Biotech with a short position of SciVision Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maxigen Biotech and SciVision Biotech.

Diversification Opportunities for Maxigen Biotech and SciVision Biotech

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Maxigen and SciVision is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Maxigen Biotech and SciVision Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SciVision Biotech and Maxigen Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maxigen Biotech are associated (or correlated) with SciVision Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SciVision Biotech has no effect on the direction of Maxigen Biotech i.e., Maxigen Biotech and SciVision Biotech go up and down completely randomly.

Pair Corralation between Maxigen Biotech and SciVision Biotech

Assuming the 90 days trading horizon Maxigen Biotech is expected to generate 19.83 times less return on investment than SciVision Biotech. But when comparing it to its historical volatility, Maxigen Biotech is 1.25 times less risky than SciVision Biotech. It trades about 0.02 of its potential returns per unit of risk. SciVision Biotech is currently generating about 0.36 of returns per unit of risk over similar time horizon. If you would invest  10,600  in SciVision Biotech on November 4, 2024 and sell it today you would earn a total of  1,700  from holding SciVision Biotech or generate 16.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Maxigen Biotech  vs.  SciVision Biotech

 Performance 
       Timeline  
Maxigen Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Good
Over the last 90 days Maxigen Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly abnormal basic indicators, Maxigen Biotech showed solid returns over the last few months and may actually be approaching a breakup point.
SciVision Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days SciVision Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly abnormal basic indicators, SciVision Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Maxigen Biotech and SciVision Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Maxigen Biotech and SciVision Biotech

The main advantage of trading using opposite Maxigen Biotech and SciVision Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maxigen Biotech position performs unexpectedly, SciVision Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SciVision Biotech will offset losses from the drop in SciVision Biotech's long position.
The idea behind Maxigen Biotech and SciVision Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments